Aion Therapeutic Inc. announced the appointment of Dr. Herbert Fritsche, former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, MD Anderson Cancer Center in Houston, Texas as Chief Science Officer. Dr. Fritsche is a Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, MD Anderson Cancer Center in Houston, Texas for 41 years. Additionally, Dr. Fritsche served as an invited consultant/advisor to the Food and Drug Administration, the National Cancer Institute, on the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry, on the Editorial Board of six international scientific journals, and as a consultant to many major international diagnostic companies. Previously, he served on the Expert Panel for developing Tumor Marker Practice Guidelines for the American Society of Clinical Oncology (ASCO) from its inception until his retirement from MD Anderson Cancer Center.